Share Twitter LinkedIn Facebook Email Sudipto Mukherjee M.D., hematology oncology physician at Cleveland Clinic Discusses Reasoning Behind ALL As Second Cancer Studyy At The 60th ASH Annual Meeting on Dec 1, 2018.
